Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05916430 · ClinicalTrials.gov registry record
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
A clinical trial of Autism and Infant Development, sponsored by Emory University.
- Recruiting
- Registry status
- 2,120
- Enrollment target
- 2
- Study locations
NCT05916430 is a study of Autism and Infant Development that is actively recruiting participants, run by Emory University. The registered enrollment target is 2,120 participants, above the 163-participant average among 104 other Autism trials with a reported enrollment target (1201% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT05916430, a study of Autism and Infant Development, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- 2,120 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST EarliPoint Investigational Device
Study Locations (2)
Georgia
- Children's Healthcare of Atlanta - Atlanta
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,120 participants |
| Start Date | 2023-02-02 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05916430
The ClinicalTrials.gov registry entry for NCT05916430 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 163-participant average among 104 other Autism trials with a reported enrollment target (1201% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which EarliPoint Investigational Device is the first listed.
NCT05916430 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05916430 about?
NCT05916430 is a clinical study titled "Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement". The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.
What is the current status of trial NCT05916430?
This trial is currently recruiting. The enrollment target is 2,120 participants. The study started on 2023-02-02. Estimated completion is 2027-12.
What conditions does trial NCT05916430 study?
This clinical trial studies the following conditions: Autism, Infant Development.
What interventions are being tested in trial NCT05916430?
The interventions under investigation include: EarliPoint Investigational Device (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05916430?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05916430 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.